- Biosimilars are proving a tougher sell in the U.S. than expected
- Planting the stake: Landos series A hauls down $10M for LANCL2 pathway effort
- Gene therapy scope broadens, again, with immune tolerance work
- Bad combo for heart drugs: Approvals down, taking longer
- Treos readies jump into phase I cancer vaccine t...
While advocacy to raise awareness about mitochondrial diseases around the world is ongoing, these efforts get a boost each year during the third week of September, which is dedicated to Mitochondrial Disease Awareness Week. Its aim is to increase the spotlight on the need for more research to uncover new therapies.
ApoE variants are the strongest known genetic risk factor not just for Alzheimer's disease (AD), but for any disease. It was first described just about 25 years ago. "And I've worked on it since then," David Holtzman told BioWorld.
In those 25 years, it has become clear that individuals with at least one copy of the ApoE4 variant, rather than ApoE3 or the protective ApoE2, have drawn the short stick in pretty much every aspect of the disease. They are more likely to develop AD in the first place, they do so at a younger age, and the disease progresses more quickly.
READ MORE »- Gene therapy scope broadens, again, with immune tolerance work »
- Signaling inhibitor shown to direct breast cancer metastasis »
- Non-antibiotic drug found effective against Staphylococcus »
- Prenatal therapy normalizes Down syndrome mouse brains »
- Stem cells replace damaged nerves in Parkinson’s disease »
- Microbiome bugs make GPCR-targeting drugs »
- New factor helps old iPSCs »
- Depression’s pathophysiology is sex-specific, study finds »
- First integrated atlas of microRNA expression compiled »
- Drug quality from a patient’s perspectiveSeptember 10, 2017 | 2:06 PM | Posted by: Mari Serebrov
- Importation a cliché, not a CAPAAugust 04, 2017 | 11:08 PM | Posted by: Mari Serebrov
- Life and death and #BIO2017June 26, 2017 | 10:18 PM | Posted by: Marie Powers
- No choice, no free marketJune 20, 2017 | 6:35 PM | Posted by: Mari Serebrov
- Poverty, politics and preventable disease: Blurring the lines between truth and fiction in BioWorld’s 11th annual Summer Reading ListJune 01, 2017 | 4:13 PM | Posted by: Marie Powers
Partners in Focus
